Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery

Assay and Drug Development Technologies

Volumn 10, Issue 1, 2012, Pages 61-68

  Che, Pulin ^a   Cui, Long ^b   Kutsch, Olaf ^a   Cui, Liwang ^b   Li, Qianjun ^a  

^a University of Alabama at Birmingham   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FIREFLY LUCIFERASE; PYRIMETHAMINE PLUS SULFADOXINE;

ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIFFUSION COEFFICIENT; DRUG DEVELOPMENT; ELECTRONICS; ENZYME ASSAY; FLUORESCENCE; HEMATOCRIT; HIGH THROUGHPUT SCREENING; HUMAN; NONHUMAN; PARASITEMIA; PEPTIDE LIBRARY; PLASMODIUM FALCIPARUM; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RELIABILITY; VALIDATION PROCESS;

ANIMALS; ANTIMALARIALS; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; LUCIFERASES, FIREFLY; ORGANISMS, GENETICALLY MODIFIED; PLASMODIUM FALCIPARUM;

EID: 84863233246     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.0378     Document Type: Article

References (33)

1. Cui L, Su XZ: Discovery, mechanisms of action and combination therapy of artemisinin. Expert Rev Anti Infect Ther 2009;7:999-1013.
2. Greenwood B: Intermittent preventive antimalarial treatment in infants. Clin Infect Dis 2007;45:26-28. (Pubitemid 46984611)
3. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434: 214-217. (Pubitemid 40388051)
4. White LJ, Maude RJ, Pongtavornpinyo W, et al.: The role of simple mathematical models in malaria elimination strategy design. Malaria J 2009;8:212.
5. Hayton K, Su XZ: Genetic and biochemical aspects of drug resistance in malaria parasites. Curr Drug Targets Infect Disord 2004;4:1-10. (Pubitemid 38404692)
6. Travassos MA, Laufer MK: Resistance to antimalarial drugs: Molecular, pharmacologic, and clinical considerations. Pediatr Res 2009;65(5 Pt 2): 64R-70R.
7. Ashley EA, White NJ: Artemisinin-based combinations. Curr Opin Infect Dis 2005;18:531-536. (Pubitemid 41634767)
8. Dondorp AM, Nosten F, Yi P, et al.: Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-467.
9. Alker AP, Lim P, Sem R, et al.: Pfmdr1 and in vivo resistance to artesunatemefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 2007;76:641-647. (Pubitemid 351627700)
10. Co EM, Dennull RA, Reinbold DD, Waters NC, Johnson JD: Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria SYBR green I-based fluorescence assay. Antimicrob Agents Chemother 2009;53:2557-2563.
11. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD: Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 1979;16:710-718. (Pubitemid 10082023)
12. Bacon DJ, Latour C, Lucas C, Colina O, Ringwald P, Picot S: Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother 2007;51: 1172-1178. (Pubitemid 46586790)
13. Fabre R, Berry A, Morassin B, Magnaval JF: Comparative assessment of conventional PCR with multiplex real-time PCR using SYBR Green I detection for the molecular diagnosis of imported malaria. Parasitology 2004;128(Pt 1): 15-21. (Pubitemid 38177801)
14. Izumiyama S, Omura M, Takasaki T, Ohmae H, Asahi H: Plasmodium falciparum: Development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer. Exp Parasitol 2009;121:144-150.
15. Rason MA, Randriantsoa T, Andrianantenaina H, Ratsimbasoa A, Menard D: Performance and reliability of the SYBR Green I based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans R Soc Trop Med Hyg 2008;102:346-351.
16. Johnson JD, Dennull RA, Gerena L, Lopez-Sanchez M, Roncal NE, Waters NC: Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother 2007;51:1926-1933. (Pubitemid 46903075)
17. Vossen MG, Pferschy S, Chiba P, Noedl H: The SYBR Green I malaria drug sensitivity assay: Performance in low parasitemia samples. Am J Trop Med Hyg 2010;82:398-401.
18. Kadekoppala M, Kline K, Akompong T, Haldar K: Stable expression of a new chimeric fluorescent reporter in the human malaria parasite Plasmodium falciparum. Infect Immun 2000;68:2328-2332. (Pubitemid 30164871)
19. Sanchez BA, Varotti FP, Rodrigues FG, Carvalho LH: Validation of a Plasmodium falciparum parasite transformed with green fluorescent protein for antimalarial drug screening. J Microbiol Methods 2007;69:518-522. (Pubitemid 46670374)
20. Cui L, Miao J, Wang J, Li Q: Plasmodium falciparum: Development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Exp Parasitol 2008;120:80-87.
21. Trager W, Jensen JB: Human malaria parasites in continuous culture. Science 1976;193:673-675.
22. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M: Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob Agents Chemother 2004;48:1803-1806. (Pubitemid 38544392)
23. Ghosh RN, DeBiasio R, Hudson CC, Ramer ER, Cowan CL, Oakley RH: Quantitative cell-based high-content screening for vasopressin receptor agonists using transfluor technology. J Biomol Screen 2005;10:476-484. (Pubitemid 41233226)
24. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73. (Pubitemid 29278954)
25. Grollman AP: Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells. J Biol Chem 1968;243:4089-4094.
26. Moller M, Herzer K, Wenger T, Herr I, Wink M: The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells. Oncol Rep 2007;18:737-744.
27. Moller M, Wink M: Characteristics of apoptosis induction by the alkaloid emetine in human tumour cell lines. Planta Med 2007;73:1389-1396. (Pubitemid 350084458)
28. Abiodun OO, Gbotosho GO, Ajaiyeoba EO, et al.: Comparison of SYBR Green I-, PicoGreen-, and [3H]-hypoxanthine-based assays for in vitro antimalarial screening of plants from Nigerian ethnomedicine. Parasitol Res 2010;106:933-939.
29. Baniecki ML, Wirth DF, Clardy J: High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother 2007;51:716-723. (Pubitemid 46185294)
30. Cervantes S, Prudhomme J, Carter D, et al.: High-content live cell imaging with RNA probes: Advancements in high-throughput antimalarial drug discovery. BMC Cell Biol 2009;10:45.
31. Elabbadi N, Ancelin ML, Vial HJ. Phospholipid metabolism of serine in Plasmodium-infected erythrocytes involves phosphatidylserine and direct serine decarboxylation. Biochem J 1997;324(Pt 2):435-445. (Pubitemid 27267985)
32. Lucumi E, Darling C, Jo H, et al. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized highthroughput luciferase-based assay. Antimicrob Agents Chemother 2010; 54:3597-3604.
33. Yuan J, Johnson RL, Huang R, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol 2009:5:765-771.